Penserra Capital Management’s iShares US Medical Devices ETF IHI Stock Holding History

Penserra Capital Management’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-69,243	Closed	-$4.06M	–	1308
2024 Q1	$4.06M	Buy	69,243 +11,103	+19%	+$627K	0.05%	250
2023 Q4	$3.14M	Buy	58,140 +49,980	+613%	+$2.44M	0.06%	209
2023 Q3	$395K	Buy	+8,160	New	+$434K	0.01%	586
2019 Q4	–	Sell	-26,520	Closed	-$1.09M	–	926
2019 Q3	$1.09M	Buy	+26,520	New	+$1.09M	0.09%	229
2019 Q2	–	Sell	-123,540	Closed	-$4.63M	–	825
2019 Q1	$4.63M	Buy	+123,540	New	+$4.49M	0.37%	79
2018 Q4	–	Sell	-66,270	Closed	-$2.51M	–	706
2018 Q3	$2.51M	Buy	+66,270	New	+$2.36M	0.15%	90

Other funds holding IHI

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Penserra Capital Management's IHI Position: Q2 2024 in Review

Penserra Capital Management sold out of iShares US Medical Devices ETF (IHI) in Q2 2024, closing a stake of 69,243 shares — an estimated $4.06M sold.

Penserra Capital Management first reported a position in IHI in Q3 2018 and held it in 6 quarters. The position peaked at $4.63M in Q1 2019. 546 funds tracked by Wall St. Rank hold IHI as of Q2 2024.

Penserra Capital Management reported no remaining iShares US Medical Devices ETF position as of Q2 2024 after selling out during the quarter.
Penserra Capital Management sold 69,243 iShares US Medical Devices ETF shares in Q2 2024, an estimated $4.06M.
Penserra Capital Management first reported a position in iShares US Medical Devices ETF in Q3 2018 and held it in 6 quarters.
Penserra Capital Management's iShares US Medical Devices ETF position peaked at $4.63M in Q1 2019.
546 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2024.

Based on Penserra Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.